Vir Biotechnology (VIR) Operating Margin (QoQ) (2018 - 2026)
Vir Biotechnology (VIR) Operating Margin (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Vir Biotechnology | 1.28 Bn | 1.28 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.61 Mn |
| Dec 31, 2025 | 7.22 Mn |
| Sep 30, 2025 | -6.25 Mn |
| Jun 30, 2025 | -515,181.00 |
| Mar 31, 2025 | -365,573.00 |
| Dec 31, 2024 | 877,191.00 |
| Sep 30, 2024 | -455,996.00 |
| Jun 30, 2024 | -500,380.00 |
| Mar 31, 2024 | 67,322.00 |
| Dec 31, 2023 | 624,775.00 |
| Sep 30, 2023 | -140,860.00 |
| Jun 30, 2023 | -543,954.00 |
| Mar 31, 2023 | 7,687.00 |
| Dec 31, 2022 | -35,665.00 |
| Sep 30, 2022 | 60,639.00 |
| Jun 30, 2022 | -63,660.00 |
| Mar 31, 2022 | 1,191.00 |
| Dec 31, 2021 | 12,187.00 |
| Sep 30, 2021 | -8,778.00 |
| Jun 30, 2021 | 806,424.00 |